Novonesis share price logo

Novonesis

NASDAQ: NVZMY

Large Cap

$64.22

-0.23

(-0.36%)

as on

Novonesis Stock Performance

as on August 19, 2026 at 6:51 am IST

  • Day's Low

    Day's High

    $63.74
    $64.39
    downward going graph

    0.75%

    Downside

    0.26%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Novonesis share price movements today

Previous Close
$64.45
Open
$63.78
Volume
23.3K
Market Cap
$30.6B
Dividend Yield
1.56%
Day's Low - High
$63.74 - $64.39

Novonesis Historical Returns

1 Month Return
+ 1.27 %
3 Month Return
+ 12.03 %
1 Year Return
+ 1 %
3 Year Return
+ 48.51 %
5 Year Return
0 %

Novonesis Stock Fundamentals & Key Indicators

Check Novonesis market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$30.6B

EPS (TTM)

1.0589

Dividend Yield

1.56%

PE Ratio (TTM)

42.3

Industry PE ratio

21.18625

PEG Ratio

0.9064220454545443

Return On Equity TTM

5.52%

Novonesis Stock Valuation

Track how Novonesis P/E has moved over time to understand its valuation trends.

Novonesis in the last 5 years

  • Overview

  • Trends

Lowest (26.57x)

December 31, 2022

Industry (21.19x)

December 31, 2025

Today (299.68x)

December 31, 2025

Highest (2714.99x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 299.68x

Novonesis vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Novonesis with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$30.6BNA42.354.33%1.5599999999999998%
HOLD$77.4B24.77%37.0612.57%102.84%
BUY$87.2B17.77%33.0249.07%0.88%
BUY$222.5B54.96%30.7345.64%1.3%
BUY$68.8B9.79%-1468.8532.06%2.36%

Stock Returns calculator for Novonesis Stock including INR - Dollar returns

The Novonesis stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Novonesis investment value today

Current value as on today

₹1,08,276

Returns

₹8,276

(+8.28%)

Returns from Novonesis Stock

-₹1,185 (-1.18%)

Dollar Impact

₹9,460 (+9.46%)

Indian Investors' Interest in Novonesis Stock

Search interest for Novonesis Stock has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:14% versus previous 30 day period

Novonesis Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
4,603
915
914
1,000
-20,611
144
136
1,060
996
1,137
Gross Profit
2,485
383
383
613
-10,050
79
72
541
558
644
Operating Income
955
66
109
182
58
35
25
236
187
272
EBITDA
1,188
150
150
346
58
36
29
331
270
424
Interest Expense
25
2
3
18
4
2
2
14
16
8
Depreciation
145
39
39
36
166
144
154
145
91
152
Income Before Tax
923
44
44
163
43
32
23
170
152
261
Income Tax Expense
228
13
13
42
11
7
5
33
29
58
Net Income
698
31
31
120
32
24
18
137
-765
202
Net Profit Margin
53.99%
41.87%
41.87%
61.26%
48.76%
55.15%
53.46%
51.08%
56.07%
56.66%

Novonesis Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
14,531
14,390
14,374
14,012
14,951
17,553
17,899
513
4,157
Gross Profit
8,413
8,255
7,954
7,853
8,623
9,577
9,722
242
2,241
Operating Income
4,047
4,070
4,039
3,652
4,073
4,561
3,976
663
882
EBITDA
5,088
5,295
5,067
4,818
5,400
6,115
5,471
1,081
1,386
Interest Expense
27
36
113
63
102
154
23
76
9
Depreciation
968
1,046
1,167
1,234
1,374
1,457
1,389
239
574
Income Before Tax
3,876
3,936
3,799
3,521
4,091
4,556
3,909
55
743
Income Tax Expense
756
709
644
695
779
870
870
14
153
Net Income
3,119
3,226
3,154
2,825
3,146
3,676
3,024
40
583
Net Profit Margin
57.90%
57.37%
55.34%
56.04%
57.68%
54.56%
54.32%
47.20%
53.91%

Novonesis Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
695
31
31
120
241
186
136
137
122
202
Operating Cash Flow
1,122
263
263
245
491
106
320
3,458
328
169
Investing Cash Flow
-603
-30
-24
-45
-144
-38
-1,541
-1,591
-226
-94
Financing Cash Flow
-555
-89
-283
-203
-329
-102
1,309
-2,212
-102
-26
Change in Cash
-59
63
48
22
19
-30
78
-348
-6
46

Novonesis Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
3,120
3,227
3,155
2,826
3,145
3,686
3,024
305
583
Operating Cash Flow
4,063
3,679
3,196
4,355
4,062
4,006
4,152
1,019
1,221
Investing Cash Flow
-1,578
-1,392
-561
-1,524
-2,747
-2,672
-2,133
-199
-1,970
Financing Cash Flow
-2,664
-2,167
-2,644
-2,314
-1,586
-1,250
-1,889
-703
753
Change in Cash
-442
91
-12
470
-218
78
75
130
-4

Global Institutional Holdings in Novonesis

Funds
Holdings
ActivePassive
0%
SP Funds
0%

Insights on Novonesis

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, NVZMY stock has moved up by 11.0%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 996.59M → 1.13B (in $), with an average increase of 12.4% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NVZMY has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -765.19M → 202.37M (in $), with an average increase of 478.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Air Products & Chemicals, Inc. has given 4.5% return, outperforming this stock by 6.5%

About Novonesis

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; ethanol for liquefaction, saccharification, fermentation, and fiber conversion; and renewable diesel. In addition, it provides dishwashing, home cleaning, laundry, medical, and industrial and institutional cleaning services; gastrointestinal, immune, mental, women's, children's cardiometabolic, and oral human health solutions. Further, the company offers corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; silage, diary and beef cattle, poultry, swine, aquaculture solutions; pet care solutions; leather and textiles solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions; and distilling, oils and fats, sustainable plastic solutions. Additionally, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S is headquartered in Lyngby, Denmark.
OrganisationNovonesis
HeadquartersBiologiens Vej 2, Lyngby, Denmark, 2800
IndustrySpecialty Chemicals
CEOMs. Ester Baiget
E-voting on sharesClick here to vote

Key Management of Novonesis

Name

Title

Mr. Andrew Taylor

Executive Vice President of Food & Beverage Biosolutions

Ms. Ester Baiget

President & CEO

Mr. Claus Crone Fuglsang

Chief Scientific Officer

Mr. Tobias Cornelius Bjorklund

Head of Investor Relations

Mr. Morten Enggaard Rasmussen

Executive Vice President of People & Stakeholder Relations

Mr. Henrik Joerck Nielsen

EVP of Human Health Biosolutions and Strategy & Integration

Mr. Rainer Lehmann

Executive VP & CFO

Mr. Anders Lund

Chief Operating Officer

Mr. Tue Micheelsen

President of Novonesis North America & Head of Global Consumer Health

Ms. Tina Sejersgaard Fano

Executive Vice President of Planetary Health Biosolutions

FAQs

What is Novonesis share price today?

Novonesis share price today is $64.22 as on at the close of the market. Novonesis share today touched a day high of $64.39 and a low of $63.74.

What is the 52 week high and 52 week low for Novonesis share?

Novonesis share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Novonesis stock price today i.e. is closed at $64.22,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Novonesis's market capitalisation today?

Novonesis market capitalisation is $0.03T as on .

How to invest in Novonesis Stock (NVZMY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Novonesis on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Novonesis Shares that will get you 0.0234 shares as per Novonesis share price of $64.22 per share as on August 19, 2026 at 1:21 am IST.

What is the minimum amount required to buy Novonesis Stock (NVZMY) from India?

Indian investors can start investing in Novonesis (NVZMY) shares with as little as ₹95.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.70 in Novonesis stock (as per the Rupee-Dollar exchange rate as on ). Based on Novonesis share’s latest price of $64.22 as on August 19, 2026 at 1:21 am IST, you will get 0.1557 shares of Novonesis. Learn more about fractional shares .